IL6 and autoimmune disease: In this study, we revealed an immunomodulatory role of lantibiotic peptides salivaricins in autoimmune disease, demonstrating that salivaricins beneficially modulate host immunity by directly binding to and inhibiting IL‐6 and IL‐21 receptors.